Conférence
Notice
Langue :
Anglais
Crédits
Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation), Jean-Michel Coindre (Intervention)
Conditions d'utilisation
Creative Commons (BY NC)
DOI : 10.60527/wmaf-0635
Citer cette ressource :
Jean-Michel Coindre. Univ Bordeaux. (2015, 10 novembre). Sarcoma Database: a unique tool for research on mesenchymal tumors , in BRIO SIRIC scientific day 3. [Vidéo]. Canal-U. https://doi.org/10.60527/wmaf-0635. (Consultée le 19 septembre 2024)

Sarcoma Database: a unique tool for research on mesenchymal tumors

Réalisation : 10 novembre 2015 - Mise en ligne : 9 décembre 2015
  • document 1 document 2 document 3
  • niveau 1 niveau 2 niveau 3
Descriptif

Clinical biology session

The main sarcoma databases are the Conticabase(https://conticabase.sarcomabcb.org) and the ConticaGist(https://conticagist.sarcomabcb.org) with 18000 patients and which collect datadescribing patient, primary tumor, histology, molecular biology, treatment andfollow-up as well as the material stored (paraffin blocks, frozen tissue,peripheral blood and cell lines). With the organization of national networks,data on practices regarding histological diagnosis and clinical management arecollected in specific databases (https://rreps.sarcomabcb.org andhttps://netsarc.sarcomabcb.org). Currently, this database contents data from45000 patients and will be soon merge with the Conticabase and ConticaGist.These databases allow studies on medical practices, medico-economical studies,description of large cohorts, pathological and molecular studies, such ashistological and molecular grading, and basic research studies such as the fullgenome sequencing in leiomyosarcomas in the context of the ICGC programme. Wenow have the project to integrate heterogeneous data, such as genomic,expression profiling and NGS data with the phenotypic data of the sarcomaBCB inthe open source platforms I2B2 and Transmart in order to make available to theclinicians a tool for the best selection of targeted treatment for homogeneousgroups of patients and to the researchers a tool for their research projects.

Cette présentation a été donnée dans le cadre du BRIO SIRICscientific day 3 organisé annuellement par le SIRIC BRIO et qui a pour but deréunir tous les acteurs du SIRIC BRIO et plus largement de la cancérologie àBordeaux.

Intervention

Dans la même collection

Sur le même thème